Clinical trial

The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced…

NCT01166347 · Medtronic Cardiac Rhythm and Heart Failure, Industry · Completed

Key facts

NCT number NCT01166347
Title The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
Official title A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Acronym ENDURANCE
Lead sponsor Medtronic Cardiac Rhythm and Heart Failure, Industry
Status Completed
Study type Interventional
Conditions Chronic Heart Failure
Intervention type Device
Interventions HeartWare® VAS, Control LVAD
Enrollment 451
Start date Aug 1, 2010
Primary completion May 1, 2014
Completion May 1, 2017
First posted Jul 21, 2010
Last update posted Sep 6, 2018
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies